| Detailed information |
|---|
| CancerLivER ID | 2528 |
| Biomarker | B-factor |
| Biomarker Name/Symbol (given in Publication) | B-factor |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential as a diagnostic marker for HCC; but not validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCC than non-tumorous tissue |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 15756260 |
| Type of Biomarker | Diagnostic |
| Pathway | Creation of C4 and C2 activators and Complement Pathway. |
| Cohort | Paired HCC and non-tumorous tissues from 16 HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2005 |
| Clinical trial | YES |
| NCT No# (Clinical trial) | NCT01974661 |